Frontlight ResearchEarly access
Duchenne muscular dystrophy trials in Puerto Rico
1 trial · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleRegistry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMIT
- Where
- San Juan
- Age
- 2 years and over
- People
- 250 worldwide
- Run by
- Catalyst Pharmaceuticals, Inc.
See details and how to joinNCT06564974